US4256832A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Carcinogen and mutagen screening method and apparatus
Assignee: Bioresearch Inc
•
Filing: 1978-12-12
•
Granted: 1981-03-17
•
Expires: 1998-12-12
Abstract
Abstract A method of screening a material for potential carcinogenic or mutagenic activity. A mutant stain of eucaryotic or prokaryotic test organism is provided which is capable of reverting to a normal form in the presence of a carcinogen or mutagen. A growth media is provided in which the test organism is capable of growth in one only of its mutant forms. For example, the test organism may be a bacteria which in its mutant form is incapable of substantial growth in the absence of an essential nutrient and, in its natural form, is capable of rapid growth in the absence of that nutrient. The test organism and growth media are combined with oxygen and a material to be screened. Oxygen consumption is then detected to determine if the mutant strain has reverted to its normal form. Reversion is indicated if a change in oxygen consumption occurs when the material being screened is present.
Inventors
- 👤 Eugene Findl
- 👤 Anthony M. Cundell
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 20:53
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/02; C12Q1/025; Y; Y10; Y10S; Y10S435/00; Y10S435/807
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
134 words
A method of screening a material for potential carcinogenic or mutagenic activity comprising: (a) providing a mutant strain of eucaryotic or prokaryotic test organism capable of reverting to a normal form in the presence of a carcinogen or mutagen; (b) providing a growth media in which the test organism is capable of rapid growth in one only of its mutant or normal forms; (c) combining said mutant strain of test organism and said growth media; (d) contacting the combined test organism and growth media with a material to be screened in the presence of oxygen; (e) detecting the consumption of oxygen resulting from step (d) to determine if said mutant strain of test organism has reverted to its normal form to thereby determine if said material to be screened is potentially carcinogenic or mutagenic.
Claim 2
Independent Claim
134 words
A method of screening a material for potential carcinogenic or mutagenic activity comprising: (a) providing a mutant strain of eucaryotic or prokaryotic test organism capable of reverting to a normal form in the presence of a carcinogen or mutagen; (b) providing a growth media in which the test organism is capable of rapid growth in one only of its mutant or normal forms; (c) combining said mutant strain of test organism and said growth media; (d) contacting the combined test organism and growth media with a material to be screened in the presence of oxygen; (e) detecting the consumption of oxygen resulting from step (d) to determine if said mutant strain of test organism has reverted to its normal form to thereby determine if said material to be screened is potentially carcinogenic or mutagenic.
Claim 3
Dependent Claim
25 words
A method according to claim 1 wherein said detecting step (e) comprises comparing said consumption of oxygen with a previously determined standard of oxygen consumption.
Claim 4
Dependent Claim
39 words
A method according to claim 1 wherein said step (e) of detecting oxygen consumption comprises positioning an oxygen electrode adjacent the combined mutant strain of test organism and growth media and analyzing an electrical output signal of said electrode.
Claim 5
Dependent Claim
96 words
A method according to claim 1 comprising providing first and second portions of the combined mutant strain of test organism and said growth media, contacting said first portion thereof with a material to be screened and oxygen according to step (d), contacting said second portion thereof with oxygen in the abscence of said material to be screened, and comparing consumption of oxygen resulting from the contacting steps to determine if said mutant strain of test organism has reverted to its normal form to thereby determine if said material to be screened is potentially carcinogenic or mutagenic.
Claim 6
Dependent Claim
58 words
A method according to claim 4 wherein comparison of oxygen consumption is effected by positioning a first oxygen electrode adjacent said first portion of combined test organism and growth media, positioning a second oxygen electrode adjacent said second portion of combined test organism and growth media, and comparing electrical output signals of the first and second oxygen electrodes.
Claim 7
Dependent Claim
73 words
A method according to claim 1 wherein said test organism, in its mutant form is substantially incapable of growth in the absence of an essential nutrient and, in its natural form, is capable of growth in the absence of said nutrient, wherein said media is substantially free of said essential nutrient, and wherein reversion of the test organism to its natural form is indicated by increased consumption of oxygen resulting from step (d).
Claim 8
Dependent Claim
19 words
A method according to claim 1 wherein said test organism comprises a mutant strain of the bacteria Salmonella typhimurium.
Claim 9
Dependent Claim
12 words
A method according to claim 7 wherein said essential nutrient is histidine.
Claim 10
Dependent Claim
74 words
A method according to claim 1 wherein said test organism, in its natural form, is substantially incapable of growth in the absence of an essential nutrient and, in its mutant form is capable of growth in the absence of said essential nutrient, wherein said media is substantially free of said essential nutrient, and wherein reversion of the test organism to its natural form is indicated by decreased consumption of oxygen resulting from step (d).
Claim 11
Dependent Claim
21 words
A method according to claim 9 wherein said test organism comprises a mutant strain of the mammalian L5i78y Murine leukemia cell.
Claim 12
Dependent Claim
12 words
A method according to claim 10 wherein said essential nutrient comprises asparagine.
Claim 13
Dependent Claim
62 words
A method according to claim 1 wherein said test organism, in its natural form, is susceptible to attack of a biocide and, in its mutant form is substantially non-susceptible to attack of said biocide, wherein said media contains said biocide, and wherein reversion of the test organism to its natural form is indicated by decreased consumption of oxyen resulting from step (d).
Claim 14
Dependent Claim
26 words
A method according to claim 12 wherein said test organism comprises a mutant strain of the yeast Saccharomyces cerevisiae and wherein said biocide comprises canavanine sulphate.
Claim 15
Dependent Claim
26 words
A method according to claim 12 wherein said test organism comprises a mutant strain of S. typhimurium TA1530 and wherein said biocide comprises L-azetidine carboxylic acid.
Claim 16
Dependent Claim
18 words
A method according to claim 1 wherein said material to be screened is present in said growth media.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-03-16 | 1984-09-15 | 1985-03-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-03-16 | 1988-09-15 | 1989-03-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-03-16 | 1992-09-15 | 1993-03-17 | $7700.00 | Window Closed / Lapsed |